Selim GÜLÜCÜ

Dr. Selim GÜLÜCÜ


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
EKEngin Kölükçü
Engin Kölükçü
SGSelim GÜLÜCÜ
Selim GÜLÜCÜ
FEFikret Erdemir
Fikret Erdemir
The aim of this study was to analyze the association between lower urinary tract symptoms and polycystic ovary syndrome.

1 March 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SGSelim GÜLÜCÜ
Selim GÜLÜCÜ
SÇSebahattin Çelik
Sebahattin Çelik
GUGökhan Unver
Gökhan Unver
The aim of this study was to investigate serum afamin levels in the first and third trimesters in preeclampsia. Serum samples from 118 patients in the first and third trimesters were analyzed. Serum samples were collected from pregnant women who had enrolled in the first trimester. Blood was then collected from pregnant women who had developed preeclampsia and from healthy controls in the third trimester. The collected blood samples were resolved for analysis, and serum afamin concentrations were measured in the first and third trimesters. Preeclampsia and healthy controls were compared. There was no significant difference between the control and preeclampsia groups in terms of age, body mass index, and smoking. Afamin levels in the first and third trimesters were higher in the preeclampsia group than in the control group (p<0.05). In the subgroup analysis of the preeclampsia group, afamin levels were higher in the early-onset preeclampsia group than in the late-onset preeclampsia group in the first and third trimesters (p<0.05). In the receiver operating characteristic analysis afamin levels were 96.23 ng/mL in the first trimester and 123.57 ng/mL in the third trimester as cut-off values for preeclampsia. Serum afamin levels are useful for predicting preeclampsia in the first trimester in pregnant women and can be used in clinical practice as a supportive biomarker for the diagnosis of preeclampsia in the third trimester. Meta-analyzes are needed to investigate the effect of afamin levels in the prediction and diagnosis of preeclampsia and to determine the cut-off value.

28 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SGSelim GÜLÜCÜ
Selim GÜLÜCÜ
ICilkin seda can caglayan
ilkin seda can caglayan
OBJECTIVE: In this study, the hormone profile, lipid profile, and inflammatory parameters of patients with polycystic ovary syndrome were compared with those of non-polycystic ovary syndrome patients to determine predictive markers in young polycystic ovary syndrome patients who have not yet had children. METHODS: Patients' age, height, weight, body mass index, waist circumference, degree of hirsutism, and ultrasound findings were recorded. Hormone profile, lipid levels, ratio of complete blood count parameters, monocyte/high-density lipoprotein ratio, and total cholesterol/high-density lipoprotein ratio were compared between groups. RESULTS: No statistically significant differences were found between groups in terms of age, weight, waist circumference, body mass index, and dysmenorrhea (p>0.05). A significant relationship was found between the height and the degree of hirsutism in the groups (p<0.05). It was found that prolactin, total testosterone, and dehydroepiandrosterone sulfate levels were statistically significantly higher in the polycystic ovary syndrome group compared to the control group. The polycystic ovary syndrome group had hemoglobin, leukocytes, lymphocytes, neutrophils, platelets, and statistically higher ratios of total cholesterol/high-density lipoprotein, Low-density lipoprotein/high-density lipoprotein, and triglycerides/high-density lipoprotein. No statistically significant relationships were found between homeostatic model assessment insulin resistance, neutrophil-to-lymphocyte ratio, and monocyte-to-high-density lipoprotein ratio between the groups (p<0.05). There was no significant difference in systemic immune inflammation index values between the groups. CONCLUSION: Polycystic ovary syndrome patients are at risk for short-and long-term complications, and the use of thetotal cholesterol/high-density lipoprotein, Low-density lipoprotein/high-density lipoprotein, and triglycerides/high-density lipoprotein ratios in clinical practice duringthefollow-up of these patients may allow easy follow-up for patients. The health status of polycystic ovary syndrome patients can be objectively determined by tracking these outcomes at regular intervals.

6 April 2022 in Ginekologia Polska
Verified
Journal Article
Closed access
PDF file
SGSelim GÜLÜCÜ
Selim GÜLÜCÜ
KUKaan Eray Uzun
Kaan Eray Uzun
Objectives: The aim of this study was to analyse the obstetric patients who underwent transfusion in the gynecology and obstetrics clinic. Material and methods: Obstetric patients who underwent a blood transfusion in the peripartum period were included in the study. A total of 213 patients who needed blood transfusion were identified. Patients' age, gravida, parity, gestational week, delivery types, blood transfusion indication and time, transfusion rate, blood products used, number of transfusions, peripartum hysterectomy status, neonatal APGAR scores and hemoglobin (Hb), hematocrit (Hct), red blood cell (RBC), platelet (Plt) values which counted before and after transfusion were recorded by scanning patient files from the hospital registry system. Results: The overall blood transfusion rate of the patients who gave birth in our clinic was 2.51%. Uterine atony (50.7%) and chronic anemia (32.9%) were found as the most frequent indications of blood transfusion in the patients included in the study. Antenatal mean Hb of all transfusion patients was 9.8; postpartum mean Hb was 8.2. Pre-transfusion mean Hb, RBC, Hct, Plt values calculated as 7, 3.9, 30.3, 245.2, respectively; post-transfusion mean Hb, RBC, Hct, Plt values were 9, 3.52, 27.5, 215.1, respectively. Conclusions: Due to blood replacement, supply difficulties and transfusion complications, the profit-loss relationship should be individualized and clearly demonstrated before it is applied to the patient. In unpredictable obstetric situations that cause bleeding, staying up to date on current guidelines on pharmacological, hematological and surgical interventions and having an active blood transfusion center in the healthcare provider is very important in reducing maternal mortality and morbidity rates. Objectives: The aim of this study was to analyse the obstetric patients who underwent transfusion in the gynecology and obstetrics clinic. Material and methods: Obstetric patients who underwent a blood transfusion in the peripartum period were included in the study. A total of 213 patients who needed blood transfusion were identified. Patients' age, gravida, parity, gestational week, delivery types, blood transfusion indication and time, transfusion rate, blood products used, number of transfusions, peripartum hysterectomy status, neonatal APGAR scores and hemoglobin (Hb), hematocrit (Hct), red blood cell (RBC), platelet (Plt) values which counted before and after transfusion were recorded by scanning patient files from the hospital registry system. Results: The overall blood transfusion rate of the patients who gave birth in our clinic was 2.51%. Uterine atony (50.7%) and chronic anemia (32.9%) were found as the most frequent indications of blood transfusion in the patients included in the study. Antenatal mean Hb of all transfusion patients was 9.8; postpartum mean Hb was 8.2. Pre-transfusion mean Hb, RBC, Hct, Plt values calculated as 7, 3.9, 30.3, 245.2, respectively; post-transfusion mean Hb, RBC, Hct, Plt values were 9, 3.52, 27.5, 215.1, respectively. Conclusions: Due to blood replacement, supply difficulties and transfusion complications, the profit-loss relationship should be individualized and clearly demonstrated before it is applied to the patient. In unpredictable obstetric situations that cause bleeding, staying up to date on current guidelines on pharmacological, hematological and surgical interventions and having an active blood transfusion center in the healthcare provider is very important in reducing maternal mortality and morbidity rates.

15 July 2018 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
FÖFiliz Özsoy
Filiz Özsoy
MYMesut Yildiz
Mesut Yildiz
SGSelim GÜLÜCÜ
Selim GÜLÜCÜ
MKMüberra Kulu
Müberra Kulu
Amaç: Doğum ağrısının algılanmasında ve ağrıya verilen cevapta etkili olan pek çok faktör vardır. Bunlar arasında; prenatal eğitim, kültür, annenin kaygı düzeyi ve kişilik yapısı sayılabilir. Biz bu çalışmada; normal doğum yapacak kadınların hissettikleri ağrı düzeyi ile kişilik yapıları ve anksiyete düzeyleri arasındaki ilişkiyi araştırmayı amaçladık. Gereç ve Yöntemler: Çalışmaya normal doğum ile doğum yapması planlanan, doğum eylemi başlayıp doğumhaneye yatırılan 101 hamile bayan dahil edildi. Hastalara Sosyodemografik ve Klinik Veri Formu, Vizüel Ağrı Skalası (VAS), Anksiyete Duyarlılığı İndeksi-3 (ADİ-3), Leiden Depresyona Duyarlılık İndeksi (LDDİ) ve Türkçe Büyük beşli ölçeği uygulandı. Bulgular: Çalışmamızda VAS ile diğer hiçbir ölçek arasında anlamlı ilişki saptanmadı (P>0,05). ADİ-3 toplam puanı ile Türkçe büyük beşli ölçeği dışa dönüklük (r=0,228) ve açıklık alt boyutları (r=0,201) arasında zayıf bir ilişki saptandı (P<0,05). Türkçe büyük beşli ölçeği dışa dönüklük alt boyutu ile ADİ-3 bilişsel (r=0,210) ve fiziksel (r=0,225) alt boyutları arasında da yine zayıf bir ilişki saptandı (P<0,05) Sonuç: Doğum eyleminde hissedilen ağrının boyutu pek çok faktöre bağlıdır. Biz çalışmamızda; doğum ağrısı ile kişilik özellikleri, anksiyete düzeyleri ve depresyon ölçeği parametreleri arasında herhangi bir anlamlı ilişki saptamadık. Fakat doğum ağrısı ve kişilik özellikleri arasındaki ilişkiyi ortaya koyabilmek için daha fazla sayıda ve daha büyük örneklem gruplarında yapılacak çalışmaya gereksinim vardır.